4-{2-[4-(Methylamino)phenyl]ethenyl}phenol | 866475-34-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 4-{2-[4-(Methylamino)phenyl]ethenyl}phenol
• 英文别名: 4-[2-[4-(methylamino)phenyl]ethenyl]phenol
• CAS: 866475-34-5
• 化学式: C₁₅H₁₅NO
• 分子量: 225.28
• InChiKey: ZWIARAQZLULYPG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• SYNTHESIS OF 18F-RADIOLABELED STYRYLPYRIDINES FROM TOSYLATE PRECURSORS AND STABLE PHARMACEUTICAL COMPOSITIONS THEREOF
  申请人：Benedum Tyler

  公开号：US20100172836A1

  公开（公告）日：2010-07-08

  The present invention relates to methods of synthesizing 18 F-radiolabeled styrylpyridine and its tosylate precursor. The present invention further relates to stable pharmaceutical compositions comprising 18 F-radiolabeled styrylpyridine.

  本发明涉及合成18F-放射标记的苯乙烯吡啶及其对甲苯磺酸酯前体的方法。本发明还涉及含有18F-放射标记的苯乙烯吡啶的稳定药物组合物。
• USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME
  申请人：Nihon Medi-Physics Co., Ltd.

  公开号：EP2218463A1

  公开（公告）日：2010-08-18

  The invention provides a reagent for detecting amyloid in a biological tissue which can be detect amyloid in vitro and in vivo with high sensitivity using a compound which has affinity with amyloid and is suppressed in toxicity such as mutagenicity. The reagent for detecting amyloid deposited in a biological tissue comprises a compound represented by the following formula (1) or a salt thereof: wherein A1, A2, A3 and A4 independently represents a carbon or nitrogen; R1 is a halogen substituent; R2 is a halogen substituent; and m is an integer or 0 to 2, provided that at least one of R1 and R2 is a radioactive halogen substituent, at least one of A1, A2, A3 and A4 represents a carbon, and R1 binds to a carbon represented by A1, A2, A3 and A4.

  该发明提供了一种用于检测生物组织中淀粉样蛋白的试剂，可以利用一种与淀粉样蛋白亲和力强且在毒性方面受到抑制（如致突变性）的化合物，在体外和体内高灵敏度地检测淀粉样蛋白。用于检测生物组织中沉积的淀粉样蛋白的试剂包括下式（1）所表示的化合物或其盐：其中A1、A2、A3和A4独立地代表碳或氮；R1是卤素取代基；R2是卤素取代基；m是整数或0到2，但至少R1和R2中的一个是放射性卤素取代基，A1、A2、A3和A4中至少一个代表碳，且R1与A1、A2、A3和A4所代表的碳结合。
• NOVEL COMPOUND WITH AMYLOID AFFINITY
  申请人：Okumura Yuki

  公开号：US20140121377A1

  公开（公告）日：2014-05-01

  A compound represented by the following formula (1), or a salt thereof: wherein R 1 is a radioactive halogen substituent, 0 to 2 of A 1 , A 2 , A 3 and A 4 represent N, and the rest represent —(CH)— is effective as a diagnostic imaging probe targeting amyloid. A diagnostic agent for Alzheimer's disease contains a compound represented by the above formula (1) or a salt thereof. After administration to a patient, the compound and the diagnostic agent for Alzheimer's disease transfer into the patient's brain, and indicate good accumulation on amyloid deposited in the brain.

  由以下公式（1）表示的化合物，或其盐：其中R1是放射性卤素取代基，A1、A2、A3和A4中的0至2个代表N，其余代表—(CH)—，作为靶向淀粉样物的诊断成像探针具有有效性。 一种用于阿尔茨海默病的诊断试剂包含上述公式（1）表示的化合物或其盐。 在向患者施用后，该化合物和用于阿尔茨海默病的诊断试剂转移到患者的大脑，并显示在大脑中沉积的淀粉上有良好的积累。
• [EN] SYNTHESIS OF 18F-RADIOLABELED STYRYLPYRIDINES FROM TOSYLATE PRECURSORS AND STABLE PHARMACEUTICAL COMPOSITIONS THEREOF<br/>[FR] SYNTHÈSE DE STYRYLPYRIDINES RADIOMARQUÉES PAR 18F À PARTIR DE PRÉCURSEURS DE TOSYLATE ET LEURS COMPOSITIONS PHARMACEUTIQUES STABLES
  申请人：AVID RADIOPHARMACEUTICALS INC

  公开号：WO2010078370A1

  公开（公告）日：2010-07-08

  The present invention relates to methods of synthesizing 18F-radiolabeled styrylpyridine and its tosylate precursor. The present invention further relates to stable pharmaceutical compositions comprising 18F-radiolabeled styrylpyridine.

  本发明涉及合成18F放射性标记的苯乙烯基吡啶及其对甲苯磺酸酯前体的方法。本发明还涉及稳定的药物组合物，包括18F放射性标记的苯乙烯基吡啶。
• Stilbene derivatives and their use for binding and imaging amyoid plaques
  申请人：Kung F. Hank

  公开号：US20060269473A1

  公开（公告）日：2006-11-30

  This invention relates to a method of imaging amyloid deposits and to labeled compounds, and methods of making labeled compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits.

  本发明涉及成像淀粉样沉积物的方法以及标记化合物，以及制备用于成像淀粉样沉积物的标记化合物的方法。本发明还涉及化合物以及制备化合物的方法，用于抑制淀粉样蛋白聚集形成淀粉样沉积物，并将治疗剂输送到淀粉样沉积物。